GPX4 and breast carcinoma: Some breast cancer cells acquire the ability of drug resistance through GPX4, namely those which are vulnerable to ferroptosis induced by GPX4 inhibition [10], suggesting that the GPX4 inhibitor might become a potential agent to overcome drug resistance in breast cancer.